s6y

10-Q Quarterly Report for period ending Sep 30, 2018

Filed
Period
Accession number
0001213900-18-015476

Documents

  1. QUARTERLY REPORT 10-Q
  2. FORM OF 2018 WARRANT EX-4.1
  3. UNIT PURCHASE AGREEMENT, DATED AS OF OCTOBER 12 AND 18, 2018, AND NOVEMBER 2, 2018 AMONG RELMADA THERAPEUTICS, INC. AND CERTAIN ACCREDITED INVESTORS EX-10.1
  4. SUBSCRIPTION AGREEMENT, DATED AS OF OCTOBER 12 AND 18, 2018, AND NOVEMBER 2, 2018 AMONG RELMADA THERAPEUTICS, INC. AND CERTAIN ACCREDITED INVESTORS EX-10.2
  5. REGISTRATION RIGHTS AGREEMENT, DATED AS OF OCTOBER 12 AND 18, 2018, AND NOVEMBER 2, 2018 AMONG RELMADA THERAPEUTICS, INC. AND CERTAIN ACCREDITED INVESTORS EX-10.3
  6. CERTIFICATION EX-31.1
  7. CERTIFICATION EX-31.2
  8. CERTIFICATION EX-32.1
  9. CERTIFICATION EX-32.2
  10. XBRL INSTANCE FILE EX-101.INS
  11. XBRL SCHEMA FILE EX-101.SCH
  12. XBRL CALCULATION FILE EX-101.CAL
  13. XBRL DEFINITION FILE EX-101.DEF
  14. XBRL LABEL FILE EX-101.LAB
  15. XBRL PRESENTATION FILE EX-101.PRE

On sec.gov